ARCH Venture Fund XII, L.P.
CIK 1906837
Transactions on file
15
Open-market buys
6
Win rate (buys)
75%
4 scored
Avg % since filing (buys)
-3.5%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | Buy | 170,000 | $3.06M | +15.4% | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 2,027,006 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 5,482,309 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 3,294,900 | $0.00 | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 7,523,682 | — | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 1,432,224 | $25.78M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 789,998 | $14.22M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 16,006,949 | — | — | open → |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | Buy | 1,100,000 | $19.80M | +21.9% | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,681,265 | $0.00 | — | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,513,686 | $0.00 | — | open → | |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 8,313,680 | $0.00 | — | open → |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 18,503,128 | $0.00 | — | open → |
| 2025-10-29 | 2025-10-27 | NMRA Neumora Therapeutics, Inc. | 10% | Buy | 1,915,700 | $5.00M | -72.0% | open → |
| 2025-08-01 | 2025-08-01 | PRME Prime Medicine, Inc. | 10% | Buy | 3,030,300 | $10.00M | +20.9% | open → |
